Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells

1.4kCitations
Citations of this article
1.2kReaders
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Despite the therapeutic potential of nucleic acid drugs, their clinical application has been limited in part by a lack of appropriate delivery systems. Exosomes or microvesicles are small endosomally derived vesicles that are secreted by a variety of cell types and tissues. Here, we show that exosomes can efficiently deliver microRNA (miRNA) to epidermal growth factor receptor (EGFR)-expressing breast cancer cells. Targeting was achieved by engineering the donor cells to express the transmembrane domain of platelet-derived growth factor receptor fused to the GE11 peptide. Intravenously injected exosomes delivered let-7a miRNA to EGFR-expressing xenograft breast cancer tissue in RAG2-/- mice. Our results suggest that exosomes can be used therapeutically to target EGFR-expressing cancerous tissues with nucleic acid drugs. © The American Society of Gene & Cell Therapy.

Cite

CITATION STYLE

APA

Ohno, S. I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., … Kuroda, M. (2013). Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells. Molecular Therapy, 21(1), 185–191. https://doi.org/10.1038/mt.2012.180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free